Do you modify your neoadjuvant considerations for patients with micropapillary histology and pT2 urothelial carcinoma and no distant neoplastic disease?
Answer from: Medical Oncologist at Academic Institution
No. The prognostic significance of this histology is uncertain (EAU Systematic Review, Veskimae et al., Eur Urol Onc 2019). Prospective well powered studies with overall survival as the primary outcome and which incorporate disease classifiers that are more accurate than histology (e.g. a molecular ...
Comments
Medical Oncologist at University of Washington School of Medicine I agree with John; I tend to offer cisplatin-based...
I agree with John; I tend to offer cisplatin-based...